Article
Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Sept 2021
Quinn Michael C J, McCue Karen, Shi Wei, Johnatty Sharon E, Beesley Jonathan, Civitarese Andrew, O'Mara Tracy A, Glubb Dylan M, Tyrer Jonathan P, Armasu Sebastian M, Ong Jue-Sheng, Gharahkhani Puya, Lu Yi, Gao Bo, Patch Ann-Marie, Fasching Peter A, Beckmann Matthias W, Lambrechts Diether, Vergote Ignace, Velez Edwards Digna R, Beeghly-Fadiel Alicia, Benitez Javier, Garcia Maria J, Goodman Marc T, Dörk Thilo, Dürst Matthias, Modugno Francesmary, Moysich Kirsten, du Bois Andreas, Pfisterer Jacobus, Bauman Klaus, Karlan Beth Y, Lester Jenny, Cunningham Julie M, Larson Melissa C, McCauley Bryan M, Kjaer Susanne K, Jensen Allan, Hogdall Claus K, Hogdall Estrid, Schildkraut Joellen M, Riggan Marjorie J, Berchuck Andrew, Cramer Daniel W, Terry Kathryn L, Bjorge Line, Webb Penelope M, Friedlander Michael, Pejovic Tanja, Moffitt Melissa, Glasspool Rosalind, May Taymaa, Ene Gabrielle E V, Huntsman David G, Woo Michelle, Carney Michael E, Hinsley Samantha, Heitz Florian, Fereday Sian, Kennedy Catherine J, Edwards Stacey L, Winham Stacey J, deFazio Anna, Pharoah Paul D P, Goode Ellen L, MacGregor Stuart, Chenevix-Trench Georgia
Abstract excerpt
BACKGROUND: Many loci have been found to be associated with risk of epithelial ovarian cancer (EOC). However, although there is considerable variation in progression-free survival (PFS), no loci have been found to be associated with outcome at genome-wide levels of significance. METHODS: We carried out a genome-wide association study (GWAS) of PFS in 2,352 women with EOC who had undergone cytoreductive surgery...
Read the complete abstract on PubMed